Drugs & Therapy Perspectives

, Volume 14, Issue 7, pp 10–10 | Cite as

Drug treatment prevents aspiration of gastric contents during delivery in pregnant women

New Drugs and Disease Management
  • 9 Downloads

Keywords

Metoclopramide Gastric Content Magnesium Hydroxide Aspiration Pneumonitis Lower Oesophageal Sphincter Pressure 

References

  1. 1.
    Bylsma-Howell M, Riggs KW, McMorland GH, et al. Placental transport of metoclopramide: assessment of maternal and neonatal effects. Can Anaesth Soc J 1983; 30: 487–92PubMedCrossRefGoogle Scholar
  2. 2.
    Vanner RG, Goodman NW. Gastro-oesophageal reflux in pregnancy, at term and after delivery. Anaesthesia 1989; 44: 808–11PubMedCrossRefGoogle Scholar
  3. 3.
    Parkman HP, Baron TH, Richter JE, et al. Gastrointestinal motility disorders during pregnancy. In: Karlstadt RG, Surawicz CM, Croitoru R, editors. Gastrointestinal disorders during pregnancy. American College of Gastroenterology, 1994; 4–14Google Scholar
  4. 4.
    Broussard CN, Richter JE. Treating gastro-oesophageal reflux disease during pregnancy and lactation: what are the safest therapy options? Drug Saf 1998 Oct; 19(4): 325–37PubMedCrossRefGoogle Scholar
  5. 5.
    Picca SM, Fiordalisi J. Treatment of gastrointestinal motility disorders in pregnancy. Ann Intern Med 1993; 119 (7 Pt 1): 635PubMedGoogle Scholar
  6. 6.
    Cheek TG, Gutsche BB. Pulmonary aspiration of gastric contents. In: Scnider SM, Levinson G, editors. Anesthesia for obstetrics. Baltimore: Williams and Wilkins, 1993: 407–31Google Scholar
  7. 7.
    Hodgkinson R, Glassenberg R, Joyce TH, et al. Comparison of Cimetidine (Tagamet) with antacid for safety and effectiveness in reducing gastric acidity before elective cesarean section. Anesthesiology 1983; 59: 86–90PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1999

Personalised recommendations